Procyon Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1804329 SHELTON, CT

Position in REGN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$378,488

-$308,388 QoQ

Shares Held

607

-31.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#333

of 584 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Procyon Advisors, LLC holds $7,050,049 across 8 Biotechnology names. REGN ranks #7 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	22,962	$2,602,972
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,924	$1,452,438
3	OCGN	Ocugen, Inc.	440,738	$674,329
4	LGND	Ligand Pharmaceuticals Inc	2,055	$649,564
5	CORT	Corcept Therapeutics Inc	5,606	$487,441
6	INVA	Innoviva, Inc.	19,097	$433,692
7	REGN	Regeneron Pharmaceuticals, Inc. This page	607	$378,488
8	CPRX	Catalyst Pharmaceuticals, Inc.	11,808	$371,125

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$378,488	607	-31.7%	Shares	Sole	2026-07-09
2026-03-31	$686,876	889	+102.0%	Shares	Sole	2026-05-04
2025-12-31	$339,622	440	-5.0%	Shares	Sole	2026-01-07
2025-09-30	$260,331	463	-12.8%	Shares	Sole	2025-10-28
2025-06-30	$278,775	531	-91.8%	Shares	Sole	2025-07-09
2025-03-31	$4,105,370	6,473	+86.0%	Shares	Sole	2025-04-11
2024-12-31	$2,479,620	3,481	-13.5%	Shares	Sole	2025-01-15
2024-09-30	$4,231,241	4,025	+6.5%	Shares	Sole	2024-10-11
2024-06-30	$3,973,944	3,781	+8.9%	Shares	Sole	2024-08-02
2024-03-31	$3,342,727	3,473	+8.4%	Shares	Sole	2024-04-15
2023-12-31	$2,814,919	3,205	+5.7%	Shares	Sole	2024-01-18
2023-09-30	$2,494,391	3,031	+150.9%	Shares	Sole	2023-10-10
2023-06-30	$867,996	1,208	+2584.4%	Shares	Sole	2023-07-17
2020-06-30	$28,064	45	0.0%	Shares	Sole	2020-08-14
2020-03-31	$21,973	45	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.